DEGs are fundamental to the concept of personalized medicine in cancer. By profiling the gene expression patterns of a patient's tumor, oncologists can identify specific molecular abnormalities and choose targeted therapies that are more likely to be effective. This approach aims to improve treatment efficacy and reduce side effects.
